CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CNE0000011K8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
59.9 ^CNY	-3.06%		-6.23%	+20.45%

15/05	CR Sanjiu Ties Up With China Resources Power on New Energy Projects	MT
19/04	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 15 June 2023

June 09, 2023 at 01:17 am IST

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. announced 2022 final profit distribution plan to be implemented (A shares) of cash dividend (tax included) of CNY 10.00000000 per 10 shares. Record date: 14 June 2023; Ex-date: 15 June 2023; Payment date: 15 June 2023.

Latest news about China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

CR Sanjiu Ties Up With China Resources Power on New Energy Projects	15/05	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04	CI
CR Sanjiu's 2023 Profit Climbs 16.5%, Revenue Jumps 37%	25/03	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Cash Dividend	25/03	CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
China Resources Sanjiu Sees Up to 32% Jump in 2023 Profit	25/01	MT
CR Sanjiu Expects Increase in 2023 Profit	25/01	MT
Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. agreed to acquire 18.7751% stake in Runsheng Pharmaceutical Co., Ltd. from Chongqing Boyi Xintian Equity Investment Fund Partnership Enterprise (Limited Partnership), Tasly Capital and Chongqing Juxin Investment Co., Ltd. for CNY 58.9 million .	06/01	CI
Respirent Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 127.97619 million in funding from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise	04/01	CI
China Resources Power Unit to Provide Financial Assistance to Affiliate	12/12	MT
CR Sanjiu Medical & Pharmaceutical Unit's Hypertension Drug Chosen for China's Centralized Procurement	08/11	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
China Resources Sanjiu to Invest Up to 3.5 Billion Yuan in Bank Financial Products	06/23/06	MT
CR Sanjiu Medical & Pharmaceutical's H1 Attributable Profit Rises 31%	30/23/30	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
CR Sanjiu Medical’s Analgesic Tablet Shortlisted For China’s Drug Procurement Program	27/23/27	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 15 June 2023	09/23/09	CI
China Resources Sanjiu Medical & Pharmaceutical's Q1 Net Profit Surges	02/23/02	MT
China Resources Power to Cooperate on New Energy Projects with China Resources Sanjiu Medical	01/23/01	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Enters into the Cooperation Agreement with China Resources Power Holdings Company Limited	28/23/28	CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022	20/23/20	CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for 2022	29/23/29	CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	12/23/12	CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022	20/23/20	CI

Chart China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Duration

Period

Chart China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

More charts

Company Profile

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily prescribed drugs, OTC drugs and generic drugs.

Sector

Pharmaceuticals

Calendar

31/05/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

59.9 CNY

Average target price

71.73 CNY

Spread / Average Target

+19.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.	+20.45%	8.18B
ELI LILLY AND COMPANY	+37.74%	723B
NOVO NORDISK A/S	+32.22%	595B
JOHNSON & JOHNSON	-2.07%	369B
MERCK & CO., INC.	+20.25%	332B
ABBVIE INC.	+2.99%	282B
ASTRAZENECA PLC	+16.60%	244B
NOVARTIS AG	+9.77%	208B
ROCHE HOLDING AG	-5.15%	205B
AMGEN INC.	+7.43%	166B

Other Pharmaceuticals